| Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised … S Rts Lancet 386 (9988), 31-45, 2015 | 2196* | 2015 |
| Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age P Bejon, J Lusingu, A Olotu, A Leach, M Lievens, J Vekemans, S Mshamu, ... New England Journal of Medicine 359 (24), 2521-2532, 2008 | 528 | 2008 |
| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 500 | 2016 |
| Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children A Olotu, G Fegan, J Wambua, G Nyangweso, A Leach, M Lievens, ... New England Journal of Medicine 374 (26), 2519-2529, 2016 | 455 | 2016 |
| Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ... New England Journal of Medicine 373 (21), 2025-2037, 2015 | 416 | 2015 |
| Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure A Olotu, G Fegan, J Wambua, G Nyangweso, KO Awuondo, A Leach, ... New England Journal of Medicine 368 (12), 1111-1120, 2013 | 358 | 2013 |
| Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites RTS, S Clinical Trials Partnership (2014) PLoS medicine 11 (7), e1001685, 2014 | 343 | 2014 |
| Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ... The Lancet infectious diseases 15 (12), 1450-1458, 2015 | 337 | 2015 |
| Efficacy of RTS, S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a … A Olotu, J Lusingu, A Leach, M Lievens, J Vekemans, S Msham, T Lang, ... The Lancet infectious diseases 11 (2), 102-109, 2011 | 218 | 2011 |
| Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study AM Aiken, N Mturi, P Njuguna, S Mohammed, JA Berkley, I Mwangi, ... The Lancet 378 (9808), 2021-2027, 2011 | 178 | 2011 |
| Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults C Ogwang, D Kimani, NJ Edwards, R Roberts, J Mwacharo, G Bowyer, ... Science translational medicine 7 (286), 286re5-286re5, 2015 | 160 | 2015 |
| Prevalence and risk factors of neurological disability and impairment in children living in rural Kenya V Mung'ala-Odera, R Meehan, P Njuguna, N Mturi, KJ Alcock, C Newton International journal of epidemiology 35 (3), 683-688, 2006 | 135 | 2006 |
| Prevalence, incidence and risk factors of epilepsy in older children in rural Kenya V Mung’ala-Odera, S White, R Meehan, GO Otieno, P Njuguna, N Mturi, ... Seizure 17 (5), 396-404, 2008 | 130 | 2008 |
| Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV-ZEBOV A Rechtien, L Richert, H Lorenzo, G Martrus, B Hejblum, C Dahlke, ... Cell reports 20 (9), 2251-2261, 2017 | 121 | 2017 |
| Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis JC Moïsi, H Gatakaa, JA Berkley, K Maitland, N Mturi, CR Newton, ... Bulletin of the World Health Organization 89 (10), 725-732, 2011 | 111 | 2011 |
| Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered … SH Hodgson, E Juma, A Salim, C Magiri, D Kimani, D Njenga, A Muia, ... Frontiers in microbiology 5, 686, 2014 | 108 | 2014 |
| Validity and reliability of the ‘Ten Questions’ questionnaire for detecting moderate to severe neurological impairment in children aged 6–9 years in rural Kenya V Mung’ala-Odera, R Meehan, P Njuguna, N Mturi, K Alcock, JA Carter, ... Neuroepidemiology 23 (1-2), 67-72, 2004 | 105 | 2004 |
| A phase 2a randomized study to evaluate the safety and immunogenicity of the 1790GAHB generalized modules for membrane antigen vaccine against Shigella sonnei administered … CW Obiero, AGW Ndiaye, AS Sciré, BM Kaunyangi, E Marchetti, AM Gone, ... Frontiers in immunology 8, 1884, 2017 | 97 | 2017 |
| Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children P Bejon, J Cook, E Bergmann-Leitner, A Olotu, J Lusingu, J Mwacharo, ... Journal of Infectious Diseases 204 (1), 9-18, 2011 | 92 | 2011 |
| Age, spatial, and temporal variations in hospital admissions with malaria in Kilifi County, Kenya: a 25-year longitudinal observational study P Mogeni, TN Williams, G Fegan, C Nyundo, E Bauni, K Mwai, I Omedo, ... PLoS medicine 13 (6), e1002047, 2016 | 89 | 2016 |
Philip BejonKEMRI-WellcomeVerified email at kemri-wellcome.org
